Skip to content
This GLP
Updated September 2026Tirzepatide only, priced per dose

Emerge Weight Loss review

A tirzepatide-only clinic that prints every dose's price and bills every four weeks, not every month.

The verdict

Emerge Weight Loss sells compounded tirzepatide from $224 per four-week fill at the 2.5 mg starting dose. Billed thirteen times a year, that comes to about $243 a calendar month. Each step up the dose ladder has its own printed price, higher than the one before.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Tirzepatide
Form
Injection
Dose pricing
Rises with dose
From
From $243/mo
Dose published
Yes
Prescription
Required
Compounded
Yes — not FDA-approved
LegitScript
Claimed by provider

Emerge is a cash-pay telehealth clinic that prescribes one injectable molecule, compounded tirzepatide, with no semaglutide line. It also markets tirzepatide care for sleep apnea and for PCOS and endometriosis. A dissolvable tirzepatide tablet is sold separately on its own page. The clinic states that it does not serve patients in California.

  1. Who writes the prescription, and what do they see?

    The site names its medical director, Sherryl Ashberg, MD, board-certified in family medicine. Nurse practitioners and a cardiologist are named beside her on the About page. The site states that a licensed provider reviews each intake before any prescription is written. Some patients are asked to submit a short intake video as part of that review. The questions on the intake form itself are not published anywhere on the site.

    Contact runs by text and email only, with published hours and a queue answered oldest message first. Virtual wellness sessions and nutrition guidance are included in the plan price. Emerge contacts the patient before each reorder, so the supply does not lapse between fills. The subscription can be canceled at any time, and the site states no minimum term.

  2. What happens when the dose goes up?

    This is where Emerge publishes more than most. Everyone starts at 2.5 mg, and the clinic moves a patient to 5 mg automatically unless asked not to. From 5 mg onward, patients reply to a reorder message to request a step up or down. The 5, 7.5 and 10 mg fills cost $239, $249 and $269, so the automatic first step also raises the bill. Two higher strengths are listed for existing patients only.

  3. What the price includes

    Four-week fills run $224, $239, $249 and $269 from 2.5 to 10 mg. The site says each fill includes medication, prescription, supplies, medical oversight and overnight shipping, with no signup or consultation fee. A four-week cycle means thirteen charges a year, about $243 a calendar month at the starting dose. A separate, lower maintenance rate applies once a goal weight is reached.

  4. What it claims, and what it cites

    The tirzepatide is compounded for each patient by a state-licensed 503A pharmacy in the United States. The site states plainly that compounded medications themselves are not FDA-approved. The pricing page does not name the pharmacy that fills a given order. The FAQ warns that concentration differs between partner pharmacies, so the strength on the label is not the dose.

Where it holds up, and where it does not

  • Strength: Every dose strength has a printed price
  • Strength: Medical director named with credentials
  • Strength: Titration schedule is described in writing
  • Strength: No minimum commitment is stated
  • Limitation: Billed every four weeks, not monthly
  • Limitation: Automatic step to 5 mg raises the bill
  • Limitation: No semaglutide option is offered
  • Limitation: California is not served

What the evidence says about this kind of treatment

The assessment above is about Emerge Weight Loss. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader set on tirzepatide who wants each dose priced before starting.
Wrong for
A reader who wants semaglutide, or who lives in California.

How Emerge Weight Loss compares

SellerWho it suitsGo
FORMA reader who has priced the manufacturer already and wants a prescriber namedSee FORM
DoctorAdamA reader weighing a tablet against an injection who wants the decision to be about the routine rather than the cost.See DoctorAdam
CLYR HealthBuyers who want the cost of each dose tier published before the first injectionSee CLYR Health
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: JentlyJoey MedJoi + BlokesJune HealthJyra HealthKERNX Health

Sponsored alternative

Bodybuilding Health+

A reader unwilling to prepay a year before seeing how the drug goes

Check Bodybuilding Health+ availability →

Frequently asked

Is $224 a monthly price?
No. It is billed every four weeks, thirteen times a year, which is about $243 per calendar month.
Does the price rise with the dose?
Yes. The 2.5 mg fill is $224, and the 5, 7.5 and 10 mg fills are $239, $249 and $269.
Will my dose go up without my asking?
The first step, from 2.5 to 5 mg, is automatic unless you ask Emerge not to. Later steps are by request.
Is Emerge Weight Loss expensive compared with other GLP-1 telehealth sellers?
Emerge Weight Loss publishes a starting figure of $243/mo. Across the 368 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $449 with a median of $189, which puts Emerge Weight Loss above the median. The other 20 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Dana SullivanEvidence reviewer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Emerge Weight Loss’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.